David Hirsch - Jul 14, 2021 Form 3 Insider Report for RAPID MICRO BIOSYSTEMS, INC. (RPID)

Role
Director, 10%+ Owner
Signature
/s/ Jonathan Paris, Attorney-in-Fact for David Hirsch
Stock symbol
RPID
Transactions as of
Jul 14, 2021
Transactions value $
$0
Form type
3
Date filed
7/14/2021, 07:30 PM
Previous filing
Jun 17, 2021
Next filing
Jul 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RPID Class A Common Stock 63.9K Jul 14, 2021 Held by Longitude Venture Partners II, L.P. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RPID Series A1 Preferred Stock Jul 14, 2021 Class A Common Stock 1.75M Held by Longitude Venture Partners II, L.P. F1, F2
holding RPID Series B1 Preferred Stock Jul 14, 2021 Class A Common Stock 1.13M Held by Longitude Venture Partners II, L.P. F1, F2
holding RPID Series C1 Preferred Stock Jul 14, 2021 Class A Common Stock 458K Held by Longitude Venture Partners II, L.P. F1, F2
holding RPID Common Warrant Jul 14, 2021 Class A Common Stock 5.56K $298.96 Held by Longitude Venture Partners II, L.P. F1, F3
holding RPID Series A1 Warrant Jul 14, 2021 Series A1 Preferred Stock 2.5M $0.01 By Longitude Venture Partners II, L.P. F1, F3
holding RPID Series B1 Warrant Jul 14, 2021 Series B1 Preferred Stock 645K $0.01 By Longitude Venture Partners II, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held directly by Longitude Venture Partners II, L.P. ("LVP II"). Longitude Capital Partners II, LLC ("LCP II"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the shares of the issuer held by LCP II. LCP II and Dr. Hirsch disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.
F2 The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the "Preferred Stock") are convertible at any time, at the holder's election and have no expiration date. Each share of Preferred Stock shall be automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering.
F3 Immediately exercisable.

Remarks:

Exhibit 24 - Power of Attorney